期刊文献+

组蛋白去乙酰化酶抑制剂抑制三阴性乳腺癌细胞增殖的实验研究 被引量:1

The research of the effect of histone deacetylase inhibitor on triple negative breast cancer cells
下载PDF
导出
摘要 背景与目的:三阴性乳腺癌(triple negative breast cancer,TNBC)是乳腺癌中的研究热点和治疗难点,目前尚无十分有效的靶向治疗药物。本研究旨在观察组蛋白去乙酰化酶抑制剂(histone deacetylase inhibitor,HDACI)对TNBC细胞增殖的影响,探讨针对组蛋白去乙酰化酶(histonedeacetylase,HDAC)的治疗对TNBC治疗的可行性。方法:将HDACI辛二酰苯胺异羟肟酸(suberoylanilidehydroxamiC acid,SAHA)作用于TNBC细胞MDA-MB-468,用MTS比色法观察细胞生长情况;用流式细胞术(theflow cytometry,FCM)检测细胞周期分布、凋亡情况,以及P21、14-3-3σ、Cyclin D1和Cyclin A2蛋白的表达状况,并进行统计分析;同时用Western blot检测以上4种蛋白的表达情况。结果:MTS比色法显示,MDA-MB-468在加入SAHA 24 h后出现细胞生长抑制并逐渐凋亡,于72 h达高峰;FCM检测显示,在加入SAHA 48 h后MDA-MB-468出现S期细胞比例下降,细胞内Cyclin A2蛋白的表达量下降,Cyclin D1、P21和14-3-3σ蛋白的表达量上升,细胞凋亡率上升,与MDA-MB-468对照组比较差异有统计学意义(P<0.05);Western blot检测结果显示,MDA-MB-468在SAHA加入48 h后Cyclin A2蛋白表达量下降,P21、14-3-3σ及Cyclin D1蛋白表达量上升。结论:SAHA是TNBC细胞增殖的高效抑制剂并促进其凋亡,其抑制作用有一定的时效关系;抑癌基因表达产物P21、14-3-3σ蛋白和周期素Cyclin D1、Cyclin A2参与了SAHA对细胞增殖周期的调控。 Background and purpose:TNBC is not only a hot research spot but also difficult type for therapy in breast cancer.Up to date,there is no sufficient effective gene therapy for it.In order to present a new approach to the gene therapy,we treated the TNBC with histone deacetylase inhibitors and observed its effects on the cell growth. Methods:We treated the TNBC cell MDA-MB-468 with histone deacetylase inhibitor SAHA.Chose the MTS to observe the cell growth arrest,selected the flow cytometry(FCM)to see the cell cycle distribution,apoptosis and the expression of Cyclin A2,Cyclin D1,P21 and 14-3-3σ.SPSS 17.0 was used to analyze the data.Meanwhile we used the Western blot to identify the expression of the above four protein.Results:From the MTS we could see that SAHA could not only inhibit the growth of MDA-MB-468 cell after adding it 24 hours but also could cause cell apoptosis and reach their peak at the time of 72 hours.From the FCM we can see the proportion of S-phase cell and the expression of Cyclin A2 were decreased after adding the SAHA 24 hours.Meanwhile the cell apoptosis and the expression of P21, 14-3-3σand Cyclin D1 were increased.The Western blot also showed the above results.Conclusion:SAHA,which could cause the death of TNBC cell MDA-MB-468,is also the most powerful histone deacetylase inhibitor for it.The effect of depression of cell growth shows time-effect relation.P21,14-3-3σ,Cyclin A2 and Cyclin D1 are involved in this regulation of cell cycle.
出处 《中国癌症杂志》 CAS CSCD 北大核心 2011年第10期777-782,共6页 China Oncology
基金 2009年留学人员科技活动项目(No:2009NS024)
关键词 辛二酰苯胺异羟肟酸 三阴性乳腺癌 P21 14-3-3σ CYCLIN A2 CYCLIN D1 SAHA Triple negative breast cancer P21 14-3-3σ Cyclin A2 Cyclin D1
  • 相关文献

参考文献19

  • 1PEART M J,SMYTH G K,VAN LAAR R K.et al. Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors[J]. Proc Natl Acad Sci USA,2005,102(10):3697-3702. 被引量:1
  • 2聂建云,刘馨,金从国,陈晓群,李佳,黄云超.组蛋白去乙酰化酶抑制剂对乳腺癌细胞株MCF-7增殖周期的影响[J].中国综合临床,2009,25(12):1238-1240. 被引量:10
  • 3GREGOIRE S,XIAO L,NIE J,et al.Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2 [J].Mol Cell Biol,2007,27(4):1280-1295. 被引量:1
  • 4聂建云,陈杨萍,黄云超.组蛋白去乙酰化酶抑制剂联合化疗对乳腺癌细胞增殖影响的动物实验研究[J].中国肿瘤临床,2011,38(4):189-192. 被引量:2
  • 5何向明,刘琳,李苏宜.组蛋白去乙酰化酶及其抑制剂与结直肠癌的关系[J].临床肿瘤学杂志,2009,14(3):270-273. 被引量:4
  • 6BRODSKA B,OTEVRELOVA P,HOLOUBEK A. Decitabine-induced apoptosis is derived by Puma and Noxa induction in chronic myeloid leukemia cell line as well as in PBL and is potentiated by SAHA[J].Mol Cell Biochem, 2011,350(1-2):71-80. 被引量:1
  • 7CHEN M Y,LIAO W S,LU Z,et al.Decitabine and suberoylanilide hydroxamic acid(SAHA)inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes,apoptosis, G2/M arrest,and autophagy [J].Cancer,2011[Epub ahead of print]. 被引量:1
  • 8TZIVION G,GUPTA V S,KAPLUN L,et al.14-3-3σproteins as potential oncogenes[J].Sem Cancer Biol,2006, 16(3):203-213. 被引量:1
  • 9TIAN H,FAJE A T,LEE S L,et al.Radiation-induced phosphorylation of Chkl at S345 is associated with p53- dependent cell cycle arrest pathways[J].Neoplasia,2002, 4(2):264-269. 被引量:1
  • 10ESTELLER M.DNA methylation and cancer therapy:new developments and expectations[J].Curr Opin Oncol,2005, 17(1):55-60. 被引量:1

二级参考文献90

共引文献45

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部